Arrowhead buys PRV for $215M; Twist hopes to raise $300M in public offering
๐ต Arrowhead Pharmaceuticals pays $215M for PRV: The drugmaker tucked into an SEC filing that it will pay that amount โ the highest price tag this year for a ...
๐ต Arrowhead Pharmaceuticals pays $215M for PRV: The drugmaker tucked into an SEC filing that it will pay that amount โ the highest price tag this year for a ...
Source: Endpoints News